| pubmed-article:8833555 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8833555 | lifeskim:mentions | umls-concept:C0683092 | lld:lifeskim |
| pubmed-article:8833555 | lifeskim:mentions | umls-concept:C0025663 | lld:lifeskim |
| pubmed-article:8833555 | lifeskim:mentions | umls-concept:C0033487 | lld:lifeskim |
| pubmed-article:8833555 | lifeskim:mentions | umls-concept:C1514468 | lld:lifeskim |
| pubmed-article:8833555 | lifeskim:mentions | umls-concept:C0014020 | lld:lifeskim |
| pubmed-article:8833555 | lifeskim:mentions | umls-concept:C0237519 | lld:lifeskim |
| pubmed-article:8833555 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:8833555 | pubmed:dateCreated | 1997-5-23 | lld:pubmed |
| pubmed-article:8833555 | pubmed:abstractText | To determine the physical compatibility of propofol injection with 77 other drug products using two methods not previously reported. | lld:pubmed |
| pubmed-article:8833555 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8833555 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8833555 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8833555 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8833555 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8833555 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8833555 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8833555 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8833555 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8833555 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:8833555 | pubmed:issn | 1060-0280 | lld:pubmed |
| pubmed-article:8833555 | pubmed:author | pubmed-author:HaasD PDP | lld:pubmed |
| pubmed-article:8833555 | pubmed:author | pubmed-author:MichaelsM RMR | lld:pubmed |
| pubmed-article:8833555 | pubmed:author | pubmed-author:StaufferG LGL | lld:pubmed |
| pubmed-article:8833555 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8833555 | pubmed:volume | 30 | lld:pubmed |
| pubmed-article:8833555 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8833555 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8833555 | pubmed:pagination | 228-32 | lld:pubmed |
| pubmed-article:8833555 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:8833555 | pubmed:meshHeading | pubmed-meshheading:8833555-... | lld:pubmed |
| pubmed-article:8833555 | pubmed:meshHeading | pubmed-meshheading:8833555-... | lld:pubmed |
| pubmed-article:8833555 | pubmed:meshHeading | pubmed-meshheading:8833555-... | lld:pubmed |
| pubmed-article:8833555 | pubmed:meshHeading | pubmed-meshheading:8833555-... | lld:pubmed |
| pubmed-article:8833555 | pubmed:meshHeading | pubmed-meshheading:8833555-... | lld:pubmed |
| pubmed-article:8833555 | pubmed:meshHeading | pubmed-meshheading:8833555-... | lld:pubmed |
| pubmed-article:8833555 | pubmed:meshHeading | pubmed-meshheading:8833555-... | lld:pubmed |
| pubmed-article:8833555 | pubmed:meshHeading | pubmed-meshheading:8833555-... | lld:pubmed |
| pubmed-article:8833555 | pubmed:meshHeading | pubmed-meshheading:8833555-... | lld:pubmed |
| pubmed-article:8833555 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:8833555 | pubmed:articleTitle | Propofol compatibility with other intravenous drug products: two new methods of evaluating IV emulsion compatibility. | lld:pubmed |
| pubmed-article:8833555 | pubmed:affiliation | Department of Pharmacy, Ohio State University Medical Center, Columbus 43210, USA. | lld:pubmed |
| pubmed-article:8833555 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8833555 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:8833555 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
